N- (2- (6- (4- cyclobutylamino- 5- trifluoromethylpyrimidine- 2- ylamino)- 1,2,3,4- tetrahydro- 1,4- epiazano- naphthalen- 9- yl)- 2- oxo- ethyl)acetamide
an aurora kinase inhibitor and antineoplastic agent; structure in first source
Also Known As:
PF 03814735; PF-03814735; PF03814735
Networked: 4
relevant articles (1 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Christensen, James G:
2 articles
(03/2012 - 04/2010)
|
2. | Akyerli, Cemaliye Boylu:
1 article
(10/2019)
|
3. | Dalva-Aydemir, Sevim:
1 article
(10/2019)
|
4. | Keskin, Hilal:
1 article
(10/2019)
|
5. | Yakıcıer, Mustafa Cengiz:
1 article
(10/2019)
|
6. | Yüksel, Şirin Kılıçturgay:
1 article
(10/2019)
|
7. | Cao, Joan:
1 article
(03/2012)
|
8. | Ching, Keith A:
1 article
(03/2012)
|
9. | Garza, Scott J:
1 article
(03/2012)
|
10. | Hook, Kenneth E:
1 article
(03/2012)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures